BlackRock Group’s MacroGenics MGNX Stock Holding History

BlackRock Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$320K	Buy	15,627 +3,977	+34%	+$100K	﹤0.01%	2510
2016 Q3	$349K	Buy	11,650 +2,817	+32%	+$83.8K	﹤0.01%	2436
2016 Q2	$238K	Sell	8,833 -111	-1%	-$2.5K	﹤0.01%	2518
2016 Q1	$168K	Buy	8,944 +3,682	+70%	+$70.1K	﹤0.01%	2628
2015 Q4	$163K	Sell	5,262 -148	-3%	-$4.5K	﹤0.01%	2568
2015 Q3	$115K	Sell	5,410 -2,928	-35%	-$91.8K	﹤0.01%	2674
2015 Q2	$317K	Buy	8,338 +5,816	+231%	+$191K	﹤0.01%	2437
2015 Q1	$79K	Sell	2,522 -3,569	-59%	-$121K	﹤0.01%	2698
2014 Q4	$214K	Sell	6,091 -38,679	-86%	-$964K	﹤0.01%	2514
2014 Q3	$936K	Buy	44,770 +3,385	+8%	+$70K	﹤0.01%	1831
2014 Q2	$899K	Buy	41,385 +15,085	+57%	+$317K	﹤0.01%	1899
2014 Q1	$732K	Hold	26,300	–	–	﹤0.01%	2108
2013 Q4	$721K	Buy	+26,300	New	+$688K	﹤0.01%	2114

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's MGNX Position: Q4 2016 in Review

BlackRock Group increased its MacroGenics (MGNX) stake by 34% in Q4 2016, buying an estimated $100K and bringing the position to 15,627 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #2510.

BlackRock Group first reported a position in MGNX in Q4 2013 and has held it in 13 quarters since. The position peaked at $936K in Q3 2014. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

BlackRock Group held 15,627 shares of MacroGenics worth $320K as of Q4 2016.
BlackRock Group bought 3,977 MacroGenics shares in Q4 2016, an estimated $100K.
MacroGenics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2510 holding.
BlackRock Group first reported a position in MacroGenics in Q4 2013 and has held it in 13 quarters since.
BlackRock Group's MacroGenics position peaked at $936K in Q3 2014.
131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.